presented by Stephen Page
Arm weakness after neurologic injury is one of the most common and debilitating impairments in all of rehabilitation. Now, you can learn the most well-known and intensively studied neurorehabilitative therapy, taught by one of its pioneers! Learn from Dr. Page, who was the first to develop and implement modified, distributed versions of constraint-induced therapy, and to show that this reimbursable outpatient approach changes the brains and movements of patients even decades after brain injury and stroke. In this introductory course, Dr. Page will introduce the rationale, scientific basis, and practical application of modified constraint induced therapy into your clinic, including applications to the upper and lower extremities and speech. Tips and techniques from this area of research are offered that can be applied to a variety of neurorehabilitative therapies.
Dr. Page’s team develops and tests approaches that increase function and independence after stroke and other neurologic diseases. He has held uninterrupted extramural funding to support his rehabilitative trials for over 15 years, and has produced many "firsts" in neurorehabilitation, developing and showing efficacy of mental practice, portable robotics, modified constraint-induced therapy, functional electrical stimulation, brain stimulation in moderately impaired individuals, and several other innovative strategies in people with acquired brain injuries. This includes eight NIH grants and five grants from the American Heart Association, as well as funding from multiple private organizations and subcontracts. He has also published well over 100 peer-reviewed articles, and has served as guest issue editor for 14 special issues of rehabilitative and neurological journals since 2001, including The Archives of Physical Medicine and Rehabilitation, The American Journal of Physical Medicine and Rehabilitation, and The Journal of Head Trauma Rehabilitation. He is a fellow of the American Heart Association, The American Congress of Rehabilitation Medicine, and The American Occupational Therapy Association, and a standing panel member on NIH's Function, Integration, and Rehabilitation Sciences Panel. While "translation" is a common buzzword in academic circles, very few clinician scientists make efforts to actually speak regularly with nonscientist audiences (such as clinicians and patients) about their findings. To accomplish such translation, Dr. Page has organized and chaired eight regional, national, and international neurorehabilitation conferences, co-chaired the 2003 and 2004 international, joint meetings of the American Society of Neurorehabilitation / the American Congress of Rehabilitation Medicine and served on the Board of Directors for these organizations. Locally, he created and co-directed the Ohio Neurorehabilitation Academy, which brings in national speakers to provide all-day, "hands-on" neurorehabilitation education to rehabilitation clinicians from across his region. He also takes great joy in providing lunch and learns to area clinicians, and outside of his region co-develops and co-implements the field's only stroke certification for physical and occupational therapists. This seminar-based program–called the "Certified Stroke Rehabilitation Specialist" (CSRS)–is another way that he translates scientific information to clinicians. You can learn more about this opportunity at www.strokecertification.com. Finally, he has mentored well over 60 students, with almost all of them at least publishing a paper and/or presenting the results of their work at a professional meeting. His mentees have won multiple awards for their work, including four "Outstanding Poster" Awards in the past two years alone at the annual international meeting of the American Congress of Rehabilitation Medicine, and four capstone awards, won by his mentees in engineering over the past four consecutive years. In 2008 Dr. Page was co-awarded the "Outstanding Mentor" Award from Xavier University.
Chapter one will describe the phenomenon of learned nonuse in neurologic populations, its relationship to neuroplasticity, the rationale and development of CIT, and challenges associated with its practical clinical administration.
This chapter details the techniques and outcome measures that are used to initiate mCIT in the clinic, including how to screen for the right candidates, the outcome measures that are used.
The last chapter of this course will introduce the user to the practical implementation of mCIT in the clinic and at home. Demonstrations will be shown to explain how the therapy is implemented and adjunctive tools used to increase its efficacy.